21.8% cases with NAFLD had significantly raised ALT level and presence of NASH.81 A study by Luxmi et al82 reported that the prevalence of fatty liver in type-2 diabetics was 60.8%, which was similar to that reported by Gupte et al13 in India (NAFLD prevalence in diabetics was 49%). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.